PMDA
- Application: Hiyasta
- Local brand name: Hiyasta
- Status: approved
Chidamide in combination with Ivonescimab (Chidamide in combination with Ivonescimab) regulatory status in Japan.
Yes. PMDA has authorised it.
Guangdong Association of Clinical Trials is the originator. The local marketing authorisation holder may differ — check the official source linked above.